Society ❯ Health Issues ❯ Obesity

Weight Management

Public Health Pharmaceutical Solutions Medication Accessibility Medication Use Dieting Trends Treatment Options Dietary Supplements Drug Accessibility Weight-loss Drugs Drug Dependency Patient Experiences Personal Experiences Consumer Health Community Support Mounjaro Public Health Initiatives Pharmaceuticals GLP-1 Drugs Medication Abuse Dietary Treatments Dietary Medications Access to Medication Patient Care Public Perception of Weight Loss Wegovy Injectable Treatments Drug Affordability Lifestyle Changes Dietary Interventions Patient Eligibility Public Health Policies

FDA Proposes Blocking Bulk Compounding of GLP-1 Drugs by Outsourcing Facilities

The move signals the agency sees no clinical need for bulk versions given improved supply.

States Curb Medicaid Coverage as First GLP‑1 Weight‑Loss Pill Debuts and Cash Prices Fall

Trump Pledges Sharp Cuts to GLP-1 Drug Prices as Novo, Lilly Shares Slide